EU sets up special committee to investigate Greens’ glyphosate herbicide reapproval concerns

h x

The European Parliament has given the green light to a special committee which aims to look into the EU’s authorisation procedure for pesticides.

The special committee said concerns have been raised about the risk posed by the herbicide substance glyphosate.

The herbicide had its marketing licence renewed by EU member states for five years in November last year.

The special committee is to assess the authorisation procedure for pesticides in the EU and potential failures in how substances are scientifically evaluated and approved.

It will also assess the role of the European Commission in renewing the glyphosate licence and possible conflicts of interest in the approval procedure.

Molly Scott Cato MEP, who sits on the European parliament’s agriculture committee, said the decision is a “victory” for Greens in Europe.

“Greens have serious concerns about whether the rules have been respected during the decision-making process for glyphosate and why scientific studies demonstrating that glyphosate is dangerous have been ignored,” Ms Cato said.

“Secret science is not science: it’s time to shine a spotlight on who is pulling the strings when it comes to authorising these potentially toxic and environmentally damaging products.”

Read full, original post: EU special committee to scrutinise authorisation procedure for glyphosate

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.